-+ 0.00%
-+ 0.00%
-+ 0.00%

Aprea Therapeutics Reports Early Proof-of-Concept for WEE1 Inhibitor APR-1051 in Solid Tumors

Reuters·01/29/2026 13:27:09

Please log in to view news